Jenni Harrison CT2 August 2013

28
Considerations in starting a Patient with Advanced Frailty on Dialysis: Complex Biology meets challenging ethics. Clin J Am Soc Neprol. 2013 Jul;8(8):1421-8. Swindler M. Jenni Harrison CT2 August 2013

description

Considerations in starting a Patient with Advanced Frailty on Dialysis: Complex Biology meets challenging ethics. Clin J Am Soc Neprol . 2013 Jul;8(8): 1421-8. Swindler M. Jenni Harrison CT2 August 2013. Overview. Frailty…….& Me The paper – technical aspects & background - PowerPoint PPT Presentation

Transcript of Jenni Harrison CT2 August 2013

Page 1: Jenni Harrison  CT2 August 2013

Considerations in starting a Patient with Advanced Frailty on Dialysis: Complex Biology

meets challenging ethics. Clin J Am Soc Neprol. 2013 Jul;8(8):1421-8. Swindler M.

Jenni Harrison CT2August 2013

Page 2: Jenni Harrison  CT2 August 2013

Overview

• Frailty…….& Me• The paper – technical aspects & background• 3 issues to discuss:

– Effects of frailty– ‘Renal Frailty Phenotype’– Ethical aspects of renal care in an ageing population

• My ‘extra slide’• Conclusions & Discussion

Image source: Google images

Page 3: Jenni Harrison  CT2 August 2013

Frailty

• What is frailty………?

Page 4: Jenni Harrison  CT2 August 2013

Frailty

………a selection of Google Definitions:(a) 2001 Psychological Thriller starring Matthew McConaughey(b) physical or moral weakness (c) the quality or state of being frail(d) the state of being weak in health or body (especially from old age)

Alternatively, a term which is becoming increasingly common, especially from Geriatricians

Image source: Google images

Page 5: Jenni Harrison  CT2 August 2013

Frailty & Geriatric Medicine

• Two broad schools of thought:– Fried, Cardiovascular Health Study

• 3 or more of: unintentional weight loss, self-reported exhaustion, weakness, slow walking speed, low physical activity levels

• Predominantly a research tool

Page 6: Jenni Harrison  CT2 August 2013

Frailty & Geriatric Medicine

• Two broad schools of thought:– Fried, Cardiovascular Health Study

• 3 or more of: unintentional weight loss, self-reported exhaustion, weakness, slow walking speed, low physical activity levels

• Predominantly a research tool– Rockwood, Frailty Index

• State of vulnerability that arises in relation to the accumulation of health deficits

• Requires rating of at least 30 health states• Difficult to apply in practice

Page 7: Jenni Harrison  CT2 August 2013

Frailty & Geriatric Medicine

• Distinct from ‘ageing’ & ‘comorbidity’• Remains an area of hot debate• A recognised concept of value, but still a question of

how it is defined– Many believe we ‘just know’ who is frail– When scales are used, their role in

decision-making/predicting outcomes is questioned (Wou et al. 2013)

– Scales/scores not used routinely in practice– ‘Difficult to operationalise’

Page 8: Jenni Harrison  CT2 August 2013

……& Me

A time to confess my conflicts of interest• Trainee geriatrician• Special interest in dementia and advanced

care planning• New to your department

Page 9: Jenni Harrison  CT2 August 2013

Single author, Mark SwindlerNew YorkReview article2013

Image source: Google images

Page 10: Jenni Harrison  CT2 August 2013

Background

• ‘Explosion’ in >80yr-olds with co-morbidities and geriatric syndromes (inc frailty)

Page 11: Jenni Harrison  CT2 August 2013

Background

• ‘Explosion’ in >80yr-olds with co-morbidities and geriatric syndromes (inc frailty)

• Dialysis ‘routine practice in the current environment of procedure-driven medical care and biomedicalisation of aging’

Page 12: Jenni Harrison  CT2 August 2013

Background

• ‘Explosion’ in >80yr-olds with co-morbidities and geriatric syndromes (inc frailty)

• Dialysis ‘routine practice in the current environment of procedure-driven medical care and biomedicalisation of aging’

• Growing group with no absolute contraindications for RRT, but are at risk for early mortality, increased hospitalisation, acceleration of geriatric syndromes and significant symptom burden

Page 13: Jenni Harrison  CT2 August 2013

Background

• ‘Explosion’ in >80yr-olds with co-morbidities and geriatric syndromes (inc frailty)

• Dialysis ‘routine practice in the current environment of procedure-driven medical care and biomedicalisation of aging’

• Growing group with no absolute contraindications for RRT, but are at risk for early mortality, increased hospitalisation, acceleration of geriatric syndromes and significant symptom burden

• ‘…..patients and families are struggling with saying no to dialysis therapy”

Page 14: Jenni Harrison  CT2 August 2013

The effects of frailty – the WHAT

• The case is forwarded that:– Dialysis patients (compared to cancer & HF)

• More hospitalisations• More ICU admissions• More hospital deaths (less hospice use)• 29% had at least 1 ‘life-sustaining’ interventions

(mechanical ventilations, CPR, feeding tube insertion)

Page 15: Jenni Harrison  CT2 August 2013

The effects of frailty – the WHAT

• The case is forwarded that:– Dialysis patients (compared to cancer & HF)

• More hospitalisations• More ICU admissions• More hospital deaths (less hospice use)• 29% had at least 1 ‘life-sustaining’ interventions

(mechanical ventilations, CPR, feeding tube insertion)– 1st year mortality dialysis patients >80 yrs up to 46%– In Nursing Home patients mortality rose, up to 58%

Page 16: Jenni Harrison  CT2 August 2013

The effects of frailty – the WHAT

• The prevalence of frailty in the CKD population is ~2x of general geriatric OP community

• Frailty assoc. with starting dialysis at a higher eGFR as well as increased mortality (attenuated when correcting for frailty)– Suggested due to ‘overlap with signs of uraemia’

• Frailty is ‘under-diagnosed’ because of the lack of uniform definition and diagnostic criteria

Page 17: Jenni Harrison  CT2 August 2013

Life expectancy Frail vs. Healthy

Page 18: Jenni Harrison  CT2 August 2013

The ‘renal frailty phenotype’ – the WHO

Page 19: Jenni Harrison  CT2 August 2013

‘Cycle of Frailty’ – trigger entry points

Page 20: Jenni Harrison  CT2 August 2013

Frail renal phenotype

Page 21: Jenni Harrison  CT2 August 2013

Ethical considerations – the WHY

• Complications– Sudden death; cardiovascular events; recurrent and

prolonged hospitalisations; infections; need for long-term care; ICU admissions; chronic critical illness; increasing frailty; functional decline; loss off independence and dialysis discontinuation with average survival of 8-10 days

– “There is no evidence that dialysis can reverse geriatric syndromes like frailty, functional disability and dementia”

Page 22: Jenni Harrison  CT2 August 2013

Ethical considerations – the WHY

• Patient’s preferences for dialysis were incorrectly predicted by surrogates/family/doctors up to ONE THIRD OF THE TIME

• Families consistently over-estimating patients’ desires to continue dialysis

• CKD & Dialysis patients experience a significant symptom burden ?inadequately assessed, ?underuse of palliative care

Page 23: Jenni Harrison  CT2 August 2013

Ethical considerations – the WHY

Page 24: Jenni Harrison  CT2 August 2013

‘Extra Slide’

• Treat with caution ‘models’ to predict risk– Inclusivity

• Referring back to ‘Frail Renal phenotype’• Multitude of overlapping factors (age, disability,

risk of sudden death, dementia, comorbidities, NH residence)

• Origins?• How helpful is this really?• …..vs clinical judgement, individualised

assessment?

Page 25: Jenni Harrison  CT2 August 2013

‘Extra Slide’

• Treat with caution ‘models’ to predict risk– Exclusivity

• An anecdote from Intercalated BSc (courtesy of University of Glasgow)

– ABCD score TIA risk prediction– Applied to clinic cohort– …….BP not predictive factor for stroke/all-

cause mortality– Depends on population used to derive the

score/scale

Page 26: Jenni Harrison  CT2 August 2013

Other Relevant Guidance

• GMC Guidance (2010) Treatment and care towards the end of life: good practice in decision making http://www.gmc-uk.org/guidance/ethical_guidance/end_of_life_care.asp

(Supersedes the previous guidance “Withholding and withdrawing life-prolonging treatments”)

Page 27: Jenni Harrison  CT2 August 2013

References

• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Med Sci. 2001;56(3):M146-56.

• Moorhouse P, Rockwood K. Frailty and its quantitative clinical evaluation. J R Coll Physicians Edin. 2012;42:333-40.

• Wou F, Gladman JR, Bradshaw L, et al. The predictive properties of frailty-rating scales in the acute medical unit. Age Ageing. 2013;May 10. Epub ahead of print.

Page 28: Jenni Harrison  CT2 August 2013

Conclusions & Discussion

• Frailty and Nephrology– WHAT– WHO– WHY

• Potential pitfalls in screening tools

OVER TO YOU……….